ALLYX THERAPEUTICS INC

Allyx Therapeutics - Reversing Neurodegeneration from Alzheimer’s Disease

ALLYX THERAPEUTICS INC was founded in 2020, is headquartered in New Haven, United States, lists 1–10 employees, and has $9.1M in recorded funding across 4 rounds.

Employees
1–10
Founded
2020
Business Model
B2G
Total Funding
$9.1M
Last Round
$3.3M Venture RoundMar 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 1 investor for this company. The full record is or through the API.

About

Allyx Therapeutics is a clinical-stage biotechnology company developing disease-modifying therapies for Alzheimer's and Parkinson's disease by targeting the underlying cause of synapse dysfunction and loss. Its lead candidate ALX-001 is an orally bioavailable small molecule that has demonstrated reversal of learning and memory deficits in preclinical models and has completed Phase 1 studies showing safety, tolerability, and full brain receptor occupancy. The company is advancing ALX-001 into Phase 2 proof-of-concept studies for both Alzheimer's and Parkinson's disease, supported by NIH SBIR grants and Alzheimer's Association funding.

Summary

ALLYX THERAPEUTICS INC is a Biotech company based in New Haven, United States, founded in 2020. It lists 1–10 employees. It has raised $9.1M in total across 4 rounds, most recently a $3.3M Venture Round in Mar 2026. Investors include National Institutes of Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundMar 2026
$3.3M

Sign up to see all 4 events

Funding: Grant through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ALLYX THERAPEUTICS INC on Indexed.vc
<a href="https://indexed.vc/companies/allyx-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/allyx-therapeutics-inc" alt="ALLYX THERAPEUTICS INC on Indexed.vc" width="260" height="76" /></a>